Matches in Nanopublications for { <http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association> ?p ?o ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- association type Statement assertion.
- association label ""Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma. Agitated states. Patients with a history of drug abuse. Known hypersensitivity or idiosyncrasy to amphetamine. In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine sulfate extended-release capsules. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products ( see ADVERSE REACTIONS Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis ( see WARNINGS and Drug Interactions"" assertion.
- association object DOID_2349 assertion.
- association predicate treats assertion.
- association subject drugbank:DB01576 assertion.
- association relation MedicalContraindication assertion.
- association provided_by NeuroDKG assertion.